Sponsored Links
| Phase 2b Data Show Treatment With STELARA(R) Induced And Maintained Clinical Response In Patients With Moderate To Severe Crohn's Disease |
 |
 |
 |
| Medical News - Crohn's | |||
|
New study findings showed that treatment with STELARA® (ustekinumab) induced and maintained clinical response in patients with moderate to severe Crohn's disease who had previously failed or were intolerant to at least one tumor necrosis factor (TNF) antagonist... Read more: Crohn's / IBD News From Medical News Today
|